Bilirubin Meters Market Size, Share Analysis, Growth Trends and Forecast 2025-2033

Bilirubin Meters Market Overview

Bilirubin Meters Market reached US$ 119.08 million in 2024 and is expected to reach US$ 304.81 million by 2033, growing at a CAGR of 11.1% during the forecast period 2025-2033.

The bilirubin meter is a device used to measure the amount of bilirubin in a patient's blood. It is an important tool in the diagnosis and treatment of neonatal jaundice. It typically uses spectrophotometric methods to measure bilirubin levels, which aids in the diagnosis and monitoring of illnesses like jaundice, liver disease, and hemolytic disorders. 

The bilirubin meters market is driven by the increasing incidence of neonatal jaundice, growing emphasis on early and accurate diagnosis, and the rising demand for non-invasive testing technologies. Advancements in transcutaneous bilirubin meters and the expansion of point-of-care testing support broader clinical adoption.

Emerging markets, especially in Asia-Pacific and Latin America, are seeing strong growth due to improving neonatal care infrastructure and government health programs. North America and Europe lead the market with robust healthcare systems and high awareness levels, while Asia-Pacific is expected to register the fastest growth over the forecast period.

Executive Summary 

Market Scope

For more details on this report – Request for Sample

Bilirubin Meters Market Dynamics: Drivers & Restraints

Technological advancement in bilirubin meters is expected to drive the market growth

Technological advancements in bilirubin meters are expected to be a key driver of market growth during the forecast period. Enhanced measuring techniques, such as advanced spectrophotometry and multi-wavelength analysis, are delivering more accurate and consistent results, increasing clinical confidence in these devices. 

The development of non-invasive meters that use light sensors to assess bilirubin levels through the skin is improving patient comfort and making routine screening more accessible. For instance, in July 2024, Konica Minolta, Inc. and Picterus AS announced the launch of a collaborative effort aimed at advancing technologies to better protect newborns from the serious health risks associated with jaundice. This partnership focuses on enhancing diagnostic solutions that enable early detection and intervention, helping to reduce the potential long-term complications of neonatal jaundice.

In addition, progress in device miniaturization and intuitive user interface design has resulted in portable, easy-to-use meters that require minimal training, enabling broader adoption across various healthcare settings. Faster analysis capabilities are also improving clinical workflow efficiency by supporting quicker diagnostic and treatment decisions. 

Furthermore, innovation is helping to reduce manufacturing costs, making these devices more affordable for healthcare providers. Collectively, these advancements are enhancing the clinical utility, affordability, and accessibility of bilirubin meters, thereby accelerating market growth globally.

The high cost of the devices is expected to hamper the bilirubin meters market 

The high cost of bilirubin meters, particularly advanced transcutaneous and bench-top models, is expected to hinder market growth, especially in low- and middle-income regions. These devices often involve significant upfront investment and ongoing maintenance expenses, which can be a financial burden for smaller hospitals, clinics, and rural healthcare centers. Additionally, the cost of calibration, replacement parts, and compatible consumables may limit their adoption in resource-constrained settings. 

Bilirubin Meters Segment Analysis

The global bilirubin meters market is segmented based on product type, age group, indication, end-user and region.

The transcutaneous segment is expected to dominate the market with the highest share of 51.7% in the global bilirubin meters market

The transcutaneous segment is expected to dominate the bilirubin meters market due to its non-invasive nature, which significantly enhances patient comfort and safety. These devices offer rapid, real-time results by measuring bilirubin levels through the skin using advanced optical sensors, enabling quicker clinical decisions and reducing the risk of infection. Their portability, ease of use, and minimal training requirements make them ideal for both hospital and point-of-care settings.

Technological advancements, such as multi-wavelength analysis and integration with electronic health records, have improved accuracy and clinical utility.  With neonatal jaundice being a major indication and healthcare systems increasingly favoring non-invasive diagnostics, the transcutaneous segment is positioned to hold the largest market share in the coming years. For instance, according to the ScienceDirect published report in 2024, globally, hyperbilirubinemia occurs in around 481,000 neonates under one month old each year, of which over 63,000 cases of moderate to severe disability.

Bilirubin Meters Market Geographical Analysis

North America is expected to hold a 41.2% share of the bilirubin meters market               

North America is expected to hold a significant position in the bilirubin meters market share due to its well-established healthcare infrastructure, high awareness of neonatal health, and early adoption of advanced medical technologies. The region benefits from strong regulatory frameworks, widespread access to healthcare services, and a high rate of hospital births, which increases the routine screening for neonatal jaundice.

Additionally, the presence of major market players, ongoing investments in research and development, and favourable reimbursement policies support the adoption of both transcutaneous and bench-top bilirubin meters. The demand for non-invasive, point-of-care diagnostics is also rising in the U.S. and Canada, further strengthening the market position. These factors collectively contribute to North America’s dominant share in the global bilirubin meters market.

Asia-Pacific is expected to hold a 23.4% share of the bilirubin meters market

Asia-Pacific is expected to be the fastest-growing region in the bilirubin meters market due to its high birth rates, increasing prevalence of neonatal jaundice, and ongoing improvements in healthcare infrastructure. Growing government initiatives focused on maternal and child health, rising healthcare awareness, and expanding access to advanced diagnostic technologies are driving demand across the region. 

Additionally, rapid urbanization, increasing healthcare expenditure, and the presence of emerging economies such as India and China contribute to the accelerated adoption of bilirubin meters. These factors collectively position Asia-Pacific as a key growth driver in the global bilirubin meters market.

Bilirubin Meters Market Segmentation

By Product Type

• Transcutaneous

• Serum Bilirubinometers

By Age Group

• Neonates

• Adults

• Geriatric

By Indication

• Hepatitis

• Jaundice

• Others

By End-User

• Hospitals

• Clinics

• Diagnostic Centers

• Others

By Region

• North America

  • The U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Rest of Europe

• South America

  • Brazil

  • Argentina

  • Rest of South America

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Rest of Asia-Pacific

• Middle East and Africa 

Bilirubin Meters Market Major Players

The major global players in the market include Delta Medical International Ltd, Mennen Medical Ltd, Ningbo David Medical Device Co. Ltd., Micro Lab Instruments, Zeal Medical, Drägerwerk AG & Co. KGaA, Labtron Equipment Ltd, Korrida Medical Systems, and GPC Medical Ltd, among others.

The is an spreadsheet The global bilirubin meters marketreport would provide approximately 53 tables, 47 figures, and 176 pages.